Physician profile
Ryan Tyner
NPI 1710583596
$4,216.29
in general payments reported to CMS, 2019-2025
24 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,204 · 2022: $993 · 2023: $1,116 · 2024: $789 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,018.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $594.98 | 2021-2025 | |
| Pfizer INC. | $523.25 | 2022-2024 | |
| Philips North America LLC | $497.85 | 2022-2024 | (Cm9) Amb Mon & Diag Und |
| Boehringer Ingelheim Pharmaceuticals, INC. | $451.71 | 2021-2024 | Jardiance, Cosela |
| Actelion Pharmaceuticals US, INC. | $443.82 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| Janssen Pharmaceuticals, INC | $350.79 | 2021-2024 | Xarelto |
| Amarin Pharma, INC. | $342.44 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $158.90 | 2021-2024 | Winrevair |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $147.20 | 2021-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $117.17 | 2022-2023 | |
| Amgen INC. | $88.50 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $71.59 | 2022-2024 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals, Ltd. | $71.47 | 2022-2023 | Arcalyst |
| Astrazeneca Pharmaceuticals Lp | $65.36 | 2021 | |
| Novo Nordisk INC | $60.79 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $41.44 | 2021-2022 | |
| Esperion Therapeutics, INC. | $30.31 | 2021 | |
| Inspire Medical Systems, INC. | $30.25 | 2023-2024 | Inspire |
| Abiomed | $29.61 | 2024 | Impella |
| Boston Scientific Corporation | $23.76 | 2023 | Watchman Flx |
| Irhythm Technologies, INC. | $21.90 | 2024 | Zio Monitor, Zio Xt Patch |
| Lexicon Pharmaceuticals, INC. | $20.18 | 2024 | |
| Silk Road Medical, INC. | $19.68 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Kowa Pharmaceuticals America, INC. | $13.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Tyner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.